TZP 101

Product NameTZP 101
CAS842131-33-3
CBNumberCB32628496
MFC30H39FN4O4
MW538.6534632
MDL NumberMFCD19443750
MOL File842131-33-3.mol
MSDS FileSDS

Chemical Properties

form	Solid
FDA UNII	LGI67MCW2S

TZP 101 Price

Product number	Packaging	Price	Product description	Buy
ChemScene CS-0003624	1mg	$639	Ulimorelin 96.10%	Buy
ChemScene CS-0003624	5mg	$1603	Ulimorelin 96.10%	Buy
ChemScene CS-0003624	10mg	$2557	Ulimorelin 96.10%	Buy
ChemScene CS-0003624	25mg	$5124	Ulimorelin 96.10%	Buy
aablocks AA00G70G	1mg	$691	D-Phenylalanine, (2S)-N-[(2R)-2-[2-(3-aminopropyl)phenoxy]propyl]-2-cyclopropylglycyl-N-methyl-D-alanyl-4-fluoro-, (3→1)-lactam >98%	Buy

TZP 101 Chemical Properties,Usage,Production

Uses

Ulimorelin (TZP-101) is a ghrelin receptor (GRLN) agonist with an EC50 of 29 nM and a Ki of 16 nM. Ulimorelin is a prokinetic agent and causes vasorelaxation through competitive antagonist action at α1-adrenoceptors. Ulimorelin stimulates intestinal motility and is used for malnutrition[1][2][3].

Definition

ChEBI: Ulimorelin is an oligopeptide.

in vivo

Ulimorelin (TZP-101; 0.3-5 mg/kg; i.v.) causes a dose dependent increase in the numbers and amplitudes of phasic pressure waves recorded from the colorectum^[1].
Ulimorelin (1, 3, 5 mg/kg; i.v.) causes a substantial and prolonged (~1 h) increase in colorectal propulsive activity and expulsion of colonic contents^[1].
Ulimorelin (p.o.; 8 mg/kg) has a C_max of 0.39 μM and a AUC of 82 μMmin for rats. Ulimorelin (i.v.; 2 mg/kg) has a T_1/2 of 50 mins, a CL of 24 mL/min/kg, and a V_ss of 1.7 L/kg for rats^[3].

Animal Model:	Male Sprague-Dawley rats^[1]
Dosage:	0.3, 1, 3, 5 mg/kg
Administration:	i.v.
Result:	Caused a dose dependent increase in the numbers and amplitudes of phasic pressure waves recorded from the colorectum.

IC 50

α adrenergic receptor

References

[1] Pustovit RV, et al. Themechanismofenhanceddefecationcausedby theghrelinreceptoragonist,ulimorelin. Neurogastroenterol Motil.2014 Feb;26(2):264-71. DOI:10.1111/nmo.12259
[2] Broad J, et al. Analysis of the ghrelin receptor-independent vascular actions of ulimorelin. Eur J Pharmacol.2015Apr 5;752:34-9. DOI:10.1016/j.ejphar.2015.02.005
[3] Hoveyda HR, et al. Optimization of the potency and pharmacokinetic properties of a macrocyclic ghrelin receptor agonist (Part I): Development of ulimorelin (TZP-101) from hit to clinic. J Med Chem. 2011 Dec 22;54(24):8305-20. DOI:10.1021/jm2007062

Preparation Products And Raw materials

TZP 101 Suppliers

Supplier	Tel	Email	Country	ProdList	Advantage
TargetMol Chemicals Inc.	+1-781-999-5354; +1-00000000000	marketing@targetmol.com	United States	32431	58
Beijing Jin Ming Biotechnology Co., Ltd.	010-60605840	psaitong@jm-bio.com	China	27626	58
RD International Technology Co., Limited	18024082417	market@ubiochem.com	China	9831	58
TargetMol Chemicals Inc.	15002134094	marketing@targetmol.cn	China	29873	58
TargetMol Chemicals Inc.	13564774135	marketing@targetmol.com	United States	19950	58

View Latest Prices from TZP 101 manufacturers

842131-33-3, TZP 101Related Search

Send Inquiry